HCA
HCA Healthcare Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.09% · Russell 1000 0.08% · US Stock Market 0.08% · Russell 3000 0.08% · MSCI ACWI 0.07% · MSCI World 0.07%$426.94+1.36%
as of market close, Sep 11, 2026
☾ AH — —
HCA — HCA Healthcare Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDD
100.0150.0200.0250.0300.0350.0400.0450.0500.0020.0M40.0M$426.94—20162019202120242026
2026-09-11
Price$426.94
MA20$414.50
MA50$437.61
Vol9.0M
Key stats
Price data
- Price
- $426.94
- Change YTD
- -8.23%
- Next earnings
- Oct 23, 2026
- Market cap
- 94.7B
- Enterprise value
- 148.1B
- Shares outstanding
- 221.8M
- 52W low
- $353.99
- 52W high
- $556.52
- From 52W high
- -23.28%
- From 52W low
- +20.61%
- 52W range
- 36%
- Beta
- 1.10
Volume
- Rel volume
- 1.05×
- 30D volume
- 1.3M
- 30D $ vol
- 520.8M
Fundamentals
- Sales (ttm)
- 76.4B
- Sales/share
- $344.34
- EPS (ttm)
- $29.05
- FCF (ttm)
- 7.9B
- FCF/share
- $35.73
- Book value/share
- -$28.41
- Net margin
- 8.89%
- ROA
- 11.06%
- Current ratio
- 0.83
Growth (CAGR, ttm) · 10Y
- Sales
- +6.71%+7.86%+7.73%n/a
- Net income
- +17.58%+5.82%+8.13%+11.78%
- FCF
- +60.26%+23.10%+1.92%+11.47%
- Shares
- -7.79%-6.93%-7.67%-5.51%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +29.32%+13.44%+16.77%+18.51%
- Sales/share
- +15.73%+15.89%+16.68%n/a
- FCF/share
- +73.80%+32.26%+10.39%+17.97%
- Dividend/share
- +8.90%+8.84%+10.68%n/a
- Price
- +5.98%+16.14%+10.71%+18.84%
- Total return
- +6.70%+17.05%+11.64%+19.75%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 14.7×
- Fwd P/E
- 12.6×
- P/S (ttm)
- 1.2×
- P/B (mrq)
- -15.0×
- P/FCF (ttm)
- 11.9×
- EV/EBITDA (fy)
- 10.1×
- EV/Sales (ttm)
- 1.9×
- FCF yield (ttm)
- 8.37%
- Dividend yield (fwd)
- 0.69%
- Dividend/share (fwd)
- $2.94
- Buyback yield (realized, 1y)
- 7.79%
- Shareholder yield (realized, 1y)
- 8.61%
- Buyback yield (cash, ttm)
- 9.64%
- Shareholder yield (cash, ttm)
- 10.36%
Vs own 10Y history
- P/E
- 63rd
- P/S
- 72nd
- P/FCF
- 31st
Bar = where today’s multiple sits in HCA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · windows as of 2026-09-11
1D
+1.36%
5D
+4.34%
1M
+2.98%
3M
+13.02%
YTD
-8.23%
1Y
+9.00%
5Y
+75.78%
Financial statements
Open full HCA financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -8.44% | -0.65% |
| JNJ | Johnson & Johnson | +2.31% | -0.29% |
| ABBV | AbbVie Inc. | +3.36% | +0.83% |
| MRK | Merck & Co. Inc. | +8.28% | -0.54% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -6.53% | -2.37% |
| TMO | Thermo Fisher Scientific Inc. | +1.13% | +1.10% |
| AMGN | Amgen Inc. | -8.80% | -1.34% |
| GILD | Gilead Sciences Inc. | +5.78% | -0.75% |
HCA Healthcare Inc. (HCA) trades at $426.94 with a live price and an interactive chart covering 15+ years of daily price history, plus key valuation metrics. ChartRow also publishes HCA’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full HCA financial statements →
